---  
layout: startup_page  
title: "Atalanta Therapeutics"  
id: "atalantatx.com"  
permalink: "/atalantatherapeuticsatalantatx.com01282025/"  
website: "https://www.atalantatx.com/"  
funding_round: "Series B"  
funding_amount: "$97M"  
investors: "EQT Life Sciences, Sanofi Ventures, RiverVest Venture Partners, funds managed by abrdn Inc, Novartis Venture Fund, Pictet Alternative Advisors, Mirae Asset Financial Group, GHR Foundation, F-Prime Capital"  
about: "Atalanta Therapeutics is a biotechnology company developing RNA interference (RNAi) therapies for neurological diseases. Their divalent small interfering RNA (di-siRNA) platform enables durable gene silencing in the brain and spinal cord. The company is advancing a pipeline of disease-modifying treatments for Huntingtonâ€™s disease, genetic epilepsy, and other neurological disorders."  
markets: "Biotechnology, RNAi, Neurological Diseases, Health Care, Life Science"  
hq: "Boston, Massachusetts, United States"  
founded_year: "2018"  
linkedin: "https://www.linkedin.com/company/atalanta-therapeutics"  
twitter: "https://twitter.com/AtalantaTx"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/atalanta-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/277170-49"  

date_display: "28-Jan-2025"  
date: "2025-01-28"

# SEO Optimization  
meta_title: "Atalanta Therapeutics - Series B Funding ($97M)"  
meta_description: "Atalanta Therapeutics, Atalanta Therapeutics is a biotechnology company developing RNA interference (RNAi) therapies for neurological diseases. Their divalent small interfer..."  
meta_keywords: "Atalanta Therapeutics, Biotechnology, RNAi, Neurological Diseases, Health Care, Life Science, Series B funding"  
canonical_url: "https://startup.projectstartups.com/atalantatherapeuticsatalantatx.com01282025/"  
---